Christine Chan

Practical considerations when treating chronic hepatitis E in solid organ transplant recipients

David K. Choi, A. Mikolajczyk, Sean Koppe, 2020, International Journal of Clinical Pharmacy.

Deaths among people with hepatitis C in New York City, 2000-2011.

S. Braunstein, K. Bornschlegel, J. Varma, 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immune‐mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct‐acting antiviral therapy

N. Terrault, T. Schiano, E. Verna, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Factors Associated With Hepatitis C Infection Among HIV-Infected Men Who Have Sex With Men With No Reported Injection Drug Use in New York City, 2000–2010

S. Braunstein, K. Bornschlegel, A. Breskin, 2015, Sexually transmitted diseases.

Incidence and risk factors for the development of cytomegalovirus viremia in a steroid sparing liver transplant center

A. Lichvar, Christine Chan, David Choi, 2022, Transplant infectious disease : an official journal of the Transplantation Society.

Infection and Alcoholic Liver Disease.

J. Levitsky, Christine Chan, 2016, Clinics in liver disease.

Diabetes Among People With Tuberculosis, HIV Infection, Viral Hepatitis B and C, and STDs in New York City, 2006-2010

J. Hadler, B. Tabaei, J. Varma, 2017, Journal of public health management and practice : JPHMP.

Glecaprevir/pibrentasvir + sofosbuvir + ribavirin offers high cure rate for hepatitis C virus retreatment in real-world settings.

L. Kulik, Michelle T. Martin, Christine Chan, 2021, Journal of hepatology.

HIV and viral hepatitis co-infection in New York City, 2000–2010: prevalence and case characteristics

S. Balter, K. Bornschlegel, C. Prussing, 2014, Epidemiology and Infection.

Infection and Alcoholic Liver Disease.

J. Levitsky, Christine Chan, 2016, Clinics in liver disease.

Characterizing idiopathic pulmonary fibrosis patients using US Medicare-advantage health plan claims data

C. Enger, K. Mortimer, L. Wallace, 2019, BMC Pulmonary Medicine.